Keyphrases
Neural Stem Cells
100%
Trisomic
100%
Down Syndrome
100%
Novel Therapeutic Targets
100%
Pharmacotherapy
37%
Intellectual Disability
37%
Cyclosporine
25%
Major Determinants
12%
Clinical Application
12%
Neurogenesis
12%
Corn Oil
12%
Novel Mechanism
12%
Molecular Mechanism
12%
Genetic Causes
12%
Cognitive Impairment
12%
Cell Dysfunction
12%
Human Pathology
12%
Cognitive Performance
12%
Thrombospondin-1 (TSP-1)
12%
Potential Interventions
12%
Ts65Dn Mice
12%
Ts65Dn
12%
Approved Drugs
12%
Euploid
12%
Brain Atrophy
12%
Astrocytic
12%
Astrogliogenesis
12%
7,8-Dihydroxyflavone (7,8-DHF)
12%
Target-based Approach
12%
Neonatal Treatment
12%
Neurogenesis Impairment
12%
Biochemistry, Genetics and Molecular Biology
Progenitor Cell
100%
Down Syndrome
100%
Intellectual Disability
37%
Drug Therapy
37%
Ciclosporin
25%
Nervous System Development
25%
Agonist
12%
Animal Model
12%
Kinase
12%
Phosphotransferase
12%
Genetics
12%
Thrombospondin 1
12%
Neuroscience
Neural Stem Cell
100%
Down Syndrome
100%
Drug Therapy
37%
Neurogenesis
25%
Ciclosporin
25%
In Vitro
12%
In Vivo
12%
Agonist
12%
Cognitive Disorders
12%
Kinase
12%
Thrombospondin 1
12%
Corn Oil
12%
Immunosuppressant
12%
Pharmacology, Toxicology and Pharmaceutical Science
Trisomy
100%
Down Syndrome
100%
Pharmacotherapy
37%
Intellectual Impairment
37%
Ciclosporin
25%
Immunosuppressive Agent
12%
Corn Oil
12%
Phosphotransferase
12%
Cognitive Defect
12%
Thrombospondin 1
12%
Brain Atrophy
12%